People · Operator
Named in public records as an officer, director or promoter · active 2020–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Larimar Therapeutics, Inc. | — | Biotechnology | Series C | $201.0M | $3.3B | 2020 |
| Orchard Therapeutics plc | — | Biotechnology | Series D+ | $184.0M | $575.8M | 2021 |
| Spero Therapeutics, Inc. | — | Biotechnology | Series C | $92.2M | $150.3M | 2021 |
Frank E. Thomas at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Frank E. Thomas on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter Barrett | 1 | 18 |
| Jean-Francois Formela | 1 | 17 |
| Scott Jackson | 1 | 13 |
| Bruce Booth | 1 | 12 |
| Jonathan Leff | 1 | 11 |
| Mitchell S. Bloom | 1 | 7 |
| Mitchell Bloom | 1 | 6 |
| Casper Breum | 1 | 5 |
| Vikas Goyal | 1 | 5 |
| Kevin Starr | 1 | 5 |
| THOMAS HUGHES | 1 | 4 |
| ANKIT MAHADEVIA | 1 | 4 |
| Milind Deshpande | 1 | 4 |
| Steven M. Altschuler | 1 | 3 |
| Lou Tartaglia | 1 | 3 |
| James A. Geraghty | 1 | 3 |
| Reza Halse | 1 | 3 |
| Bruce S. Booth | 1 | 2 |
| Joanne T. Beck | 1 | 2 |
| Frances Heller | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.